Reinier M. van Hest

University of Amsterdam

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

40%

Pharmacology

20%

Antibiotic Therapy

60%

Pharmacokinetic

30%

Drug Formulation

20%

Pharmacoepidemiology

20%

Drug Utilization

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

The Dutch list of essential drugs for undergraduate medical education: A modified Delphi study

Article Link

Year:

2023

Pharmacokinetic/Pharmacodynamic Target Attainment of Ceftazidime in Adult Patients on General Wards with Different Degrees of Renal Function: A Prospective Observational Bicenter Cohort Study

Article Link

Year:

2023

An Unusual Case of Low Vancomycin Exposure Despite Extremely High Vancomycin Doses Accompanied by Renal Toxicity: A Grand Round

Article Link

Year:

2023

On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives

Article Link

Year:

2023

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies

Article Link

Year:

2022

Persistent Borrelia burgdorferi <i>Sensu Lato</i> Infection after Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Models.

Article Link

Year:

2022

Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial.

Article Link

Year:

2022

Detecting inappropriate total duration of antimicrobial therapy using semi-automated surveillance.

Article Link

Year:

2022

Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Assay for the Determination of Total and Unbound Ciprofloxacin Concentrations in Human Plasma.

Article Link

Year:

2022

Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Assay for the Determination of Total and Unbound Ciprofloxacin Concentrations in Human Plasma

Article Link

Year:

2022

Collaborators3

Roger J M Brüggemann

Radboud University Medical Center

NETHERLANDS

Eveline van Poelgeest

NETHERLANDS

Catherijne A J Knibbe

Leiden University

NETHERLANDS

How do I reach out?

Meet Kite AI